Neflamapimod, a selective inhibitor of p38 mitogen activated protein kinase alpha (MAPKα), is under clinical investigation for its efficacy in Alzheimer's disease (AD) and dementia with …
AK Pandey, F Zerin, SN Menon, KP Nguyen, T Vo… - 2021 - scholar.archive.org
Ne amapimod, a selective inhibitor of p38 MAPKα, is under clinical investigation for its e cacy in Alzheimer's disease (AD) and dementia with Lewy Bodies (DLB). Here, we …